Authors:
Baranovskii, AG
Ershova, NA
Buneva, VN
Kanyshkova, TG
Mogelnitskii, AS
Doronin, BM
Boiko, AN
Gusev, EI
Favorova, OO
Nevinsky, GA
Citation: Ag. Baranovskii et al., Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis, IMMUNOL LET, 76(3), 2001, pp. 163-167
Authors:
Boiko, AN
Guseva, ME
Guseva, MR
Boiko, SY
Sudomoina, MA
Bikova, OV
Maslova, OI
Favorova, OO
Gusev, EI
Citation: An. Boiko et al., Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children, J NEUROVIRO, 6, 2000, pp. S152-S155
Citation: Ei. Gusev et al., Problems and perspectives of application of beta-interferons and copaxon in the treatment of multiple sclerosis, ZH NEVR PS, 99(4), 1999, pp. 33-36
Authors:
Alexeenkov, AD
Sudomoina, MA
Boiko, AN
Deomina, TL
Gusev, EI
Favorova, OO
Citation: Ad. Alexeenkov et al., Two single-base polymorphisms in the human tumor necrosis factor locus of multiple sclerosis patients from the Russian population: NcoI-RFLP in the first intron of the human lymphotoxin alpha gene correlates with the disease, MOL BIOL, 33(2), 1999, pp. 158-164
Authors:
Baranovskii, AG
Kanyshkova, TG
Mogelnitskii, AS
Naumov, VA
Buneva, VN
Gusev, EI
Boiko, AN
Zargarova, TA
Favorova, OO
Nevinsky, GA
Citation: Ag. Baranovskii et al., Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA, BIOCHEM-MOS, 63(11), 1998, pp. 1239-1248